Cargando…
Two years follow-up of golimumab treatment in refractory enteropathic spondyloarthritis patients with Crohn disease: A STROBE-compliant study
Golimumab is a fully human monoclonal antibody against tumor necrosis factor (TNF) approved for the treatment of ulcerative colitis and not for Crohn disease (CD). Many CD patients experience primary, secondary failure, or intolerance to other TNF inhibitors (TNFi) approved in Italy for CD (adalimum...
Autores principales: | Conigliaro, Paola, Chimenti, Maria Sole, Triggianese, Paola, D’Antonio, Arianna, Sena, Giorgia, Alfieri, Norma, Biancone, Livia, Perricone, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281909/ https://www.ncbi.nlm.nih.gov/pubmed/33761677 http://dx.doi.org/10.1097/MD.0000000000025122 |
Ejemplares similares
-
Genetics, Epigenetics, and Gender Impact in Axial-Spondyloarthritis Susceptibility: An Update on Genetic Polymorphisms and Their Sex Related Associations
por: Chimenti, Maria Sole, et al.
Publicado: (2021) -
Effectiveness and persistence of golimumab as a second biological drug in patients with spondyloarthritis: A retrospective study
por: Alegre-Sancho, Juan J., et al.
Publicado: (2021) -
Long-term effectiveness and drug survival of golimumab in patients affected by psoriatic arthritis with cutaneous involvement
por: Chimenti, Maria Sole, et al.
Publicado: (2021) -
The Clinical Characteristics of Primary Sjogren's Syndrome With Neuromyelitis Optica Spectrum Disorder in China: A STROBE-Compliant Article
por: Qiao, Lin, et al.
Publicado: (2015) -
Parenchymal lung involvement in adult-onset Still disease: A STROBE-compliant case series and literature review
por: Gerfaud-Valentin, Mathieu, et al.
Publicado: (2016)